Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05133037 · ClinicalTrials.gov registry record
AN/BN Risk Factors Study
A clinical trial of Eating Disorders, sponsored by Stanford University.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05133037: Active study of Eating Disorders, sponsored by Stanford University.
NCT05133037 is a study of Eating Disorders that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 50 participants, below the 321-participant average among 37 other Eating Disorders trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05133037, a study of Eating Disorders, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Across the United States, thousands of children and adolescents suffer from eating disorders. Among young women alone, an estimated 2 to 4 percent are dealing with anorexia nervosa. Anorexia nervosa also has the highest mortality rate of any psychiatric disorder and produces a six-fold increased risk for death. Unfortunately, study shows that current treatments are only successful with 25 percent of patients and no eating disorder prevention program has been found to reduce future onset of anorexia nervosa. The goal of this study is to conduct a highly innovative pilot study that will identify risk factors that predict future onset of anorexia nervosa and investigate how the risk processes for anorexia nervosa are different from the risk processes for bulimia nervosa. The proposed pilot study will: * Compare 30 healthy adolescent girls at high risk for anorexia nervosa to 30 healthy adolescent girls at high risk for bulimia nervosa, and 30 healthy adolescent girls at low risk for eating disorder in an effort to document risk processes that are present in early adolescence before anorexia nervosa typically emerges. * Test whether elevations in the hypothesized risk factors predict future onset of anorexia nervosa over a four-year follow-up.
Conditions Studied
Interventions
- DEVICE GE MR Scanner
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-23 |
| Est. Completion | 2029-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05133037
The ClinicalTrials.gov registry entry for NCT05133037 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 321-participant average among 37 other Eating Disorders trials with a reported enrollment target (84% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 1 intervention - of which GE MR Scanner is the first listed.
NCT05133037 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05133037 about?
NCT05133037 is a clinical study titled "AN/BN Risk Factors Study". Across the United States, thousands of children and adolescents suffer from eating disorders. Among young women alone, an estimated 2 to 4 percent are dealing with anorexia nervosa. Anorexia nervosa also has the highest mortality rate of any psychiatric disorder and produces a six-fold increased ris...
What is the current status of trial NCT05133037?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2021-11-23. Estimated completion is 2029-05-26.
What conditions does trial NCT05133037 study?
This clinical trial studies the following conditions: Eating Disorders.
What interventions are being tested in trial NCT05133037?
The interventions under investigation include: GE MR Scanner (DEVICE).
Who is sponsoring clinical trial NCT05133037?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05133037 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.